Phosphatase News and Research

RSS
Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

New high throughput sequencing technology to identify genetic defects in rare diseases

New high throughput sequencing technology to identify genetic defects in rare diseases

New research could extend the life of donated organs

New research could extend the life of donated organs

Injecting PAP may reduce chronic pain: Research

Injecting PAP may reduce chronic pain: Research

Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine

Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Quintiles announces comprehensive suite of PI3K biomarker assays

Quintiles announces comprehensive suite of PI3K biomarker assays

Highlights from June 2010 issue of American Journal of Pathology

Highlights from June 2010 issue of American Journal of Pathology

New study reveals PTPN2 gene loss causes bone cancer

New study reveals PTPN2 gene loss causes bone cancer

Researchers determine how cells regulate chromosome/microtubule interface

Researchers determine how cells regulate chromosome/microtubule interface

PROVENGE receives FDA approval for treatment of CRPC

PROVENGE receives FDA approval for treatment of CRPC

New theory on muscle and bone diseases

New theory on muscle and bone diseases

Study: Cigarette smoking, fructose consumption can worsen NAFLD

Study: Cigarette smoking, fructose consumption can worsen NAFLD

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

Working of master regulator protein phosphatase 1

Working of master regulator protein phosphatase 1

TB's mechanism to evade body's immune system identified

TB's mechanism to evade body's immune system identified

Study could lead to non-surgical alternatives for tonsillectomies

Study could lead to non-surgical alternatives for tonsillectomies

Breakthrough findings could lead to new treatments for prostate, brain and skin cancers

Breakthrough findings could lead to new treatments for prostate, brain and skin cancers

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission